Citigroup’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-716,402
| Closed | -$82K | – | 5262 |
|
|
2018
Q4 | $82K | Sell |
716,402
-316,427
| -31% | -$36.2K | ﹤0.01% | 3624 |
|
|
2018
Q3 | $1.76M | Buy |
1,032,829
+123,239
| +14% | +$210K | ﹤0.01% | 1595 |
|
|
2018
Q2 | $1.58M | Buy |
909,590
+205,976
| +29% | +$358K | ﹤0.01% | 1607 |
|
|
2018
Q1 | $1.29M | Sell |
703,614
-1,634,553
| -70% | -$2.99M | ﹤0.01% | 1686 |
|
|
2017
Q4 | $5.21M | Buy |
2,338,167
+555,342
| +31% | +$1.24M | ﹤0.01% | 949 |
|
|
2017
Q3 | $5.17M | Buy |
1,782,825
+874,427
| +96% | +$2.54M | ﹤0.01% | 944 |
|
|
2017
Q2 | $4.04M | Buy |
908,398
+869,762
| +2,251% | +$3.87M | ﹤0.01% | 1055 |
|
|
2017
Q1 | $180K | Sell |
38,636
-378,574
| -91% | -$1.76M | ﹤0.01% | 3031 |
|
|
2016
Q4 | $2.54M | Sell |
417,210
-371,971
| -47% | -$2.27M | ﹤0.01% | 1627 |
|
|
2016
Q3 | $4.35M | Buy |
789,181
+162,047
| +26% | +$893K | ﹤0.01% | 955 |
|
|
2016
Q2 | $2.38M | Sell |
627,134
-5,793
| -0.9% | -$22K | ﹤0.01% | 1171 |
|
|
2016
Q1 | $1.75M | Sell |
632,927
-217,280
| -26% | -$600K | ﹤0.01% | 1556 |
|
|
2015
Q4 | $4.82M | Buy |
850,207
+238,600
| +39% | +$1.35M | ﹤0.01% | 891 |
|
|
2015
Q3 | $3.24M | Buy |
611,607
+595,103
| +3,606% | +$3.15M | ﹤0.01% | 1073 |
|
|
2015
Q2 | $137K | Sell |
16,504
-1,475
| -8% | -$12.2K | ﹤0.01% | 3030 |
|
|
2015
Q1 | $83K | Sell |
17,979
-19,617
| -52% | -$90.6K | ﹤0.01% | 3528 |
|
|
2014
Q4 | $115K | Buy |
37,596
+10,909
| +41% | +$33.4K | ﹤0.01% | 3565 |
|
|
2014
Q3 | $75K | Sell |
26,687
-4,922
| -16% | -$13.8K | ﹤0.01% | 3381 |
|
|
2014
Q2 | $129K | Sell |
31,609
-10,825
| -26% | -$44.2K | ﹤0.01% | 2910 |
|
|
2014
Q1 | $225K | Sell |
42,434
-21,932
| -34% | -$116K | ﹤0.01% | 2764 |
|
|
2013
Q4 | $357K | Buy |
64,366
+18,597
| +41% | +$103K | ﹤0.01% | 2645 |
|
|
2013
Q3 | $207K | Buy |
45,769
+13,248
| +41% | +$59.9K | ﹤0.01% | 2571 |
|
|
2013
Q2 | $138K | Buy |
+32,521
| New | +$138K | ﹤0.01% | 3026 |
|